基于(关键地区、市场参与者、规模和份额)的无菌复合药房市场 - 到 2031 年的预测

  • Report Code : TIPRE00026302
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 163
Buy Now

[研究报告]无菌复方药房市场预计将从 2021 年的 39.687 亿美元增至 2028 年的 61.9859 亿美元;预计 2021 年至 2028 年复合年增长率为 6.6%。

个性化药物使用率上升以及与持续治疗相关的益处等因素现场无菌复合推动了市场的增长。然而,产品召回和严格的监管要求阻碍了市场增长。另一方面,定制配方的集中或区域复合中心的发展将为预测期内的市场增长创造有利可图的机会。

北美可能会继续在该领域占据主导地位。 2021 年至 2028 年无菌复合药房市场。美国占据北美市场最大份额,预计在预测期内将继续这一趋势。这主要归因于不断增长的医药支出和完善的医疗基础设施。例如,美国食品和药物管理局 (FDA) 指定了 503B(根据记录,503B 称为外包设施,有时也称为 503B 药房,并受到 FDA 的严格监控,建立了新的患者护理水平和安全)。此外,美国近 75% 的医院将无菌复合制剂外包给 503B 设施,以确保稳定性、应对药物短缺、获得即用型药物并延长保质期。此外,老年人口的增加以及定制配方对商业产品的日益采用预计将在未来几年推动美国无菌复合药房市场的增长。


战略洞察

无菌复合药房市场利润丰厚的区域

市场洞察

现场无菌混合的好处推动市场增长

对于要根据患者需求定制静脉溶液的情况,现场混合和灭菌至关重要。现场制造允许在早期临床药物开发的起始阶段将活性药物成分 (API) 引入人类受试者。无菌临时复合为按良好制造 (GMP) 标准设计的注射用研究产品的昂贵、扩展开发提供了灵活的选择。通常,用于临床研究的胃肠外给药 API 是在 GMP 条件下生产的。这可能会减少生产特定剂量所需的成品所需的时间。

此外,通过与制药公司的强有力合作,可以成功地将制剂混合并过滤成无菌静脉溶液。申办者和临床现场药剂师,可以有效地进行无菌测试。

现场无菌配药已在全球市场上获得了广泛关注,并且是影响无菌的最重要因素之一市场增长。这是因为无菌复方药剂师更加关注最新的研究活动、创新技术、质量控制规则,并获得最好的成分来满足患者的需求。例如,美国国家药事委员会协会 (NABP) 宣布获得美国食品和药物管理局 (FDA) 的资助,用于开发数据共享系统,以改善对无菌配制药房的监管。该新系统预计将有助于收集、管理和共享与美国无菌配制相关的信息。该项目还旨在降低受伤风险,有利于患者使用配制不当的药品。

基于产品的见解

基于在产品上,无菌复方药房市场分为注射剂和输液。注射药物细分市场将在 2021 年至 2028 年占据更大的市场份额。注射药物因其更快的作用方式而成为备受青睐的无菌复合产品之一。为了避免对患者产生任何不利影响,复合注射药物(定义为在办公室稀释、混合、重构和制备的药物)在保持适当防护措施以防止疾病和复合成分传播的环境中进行配制。药物的强度和妆容适当。市场参与者正在采用有机和无机增长策略来实现市场增长。例如,2019 年 9 月,QuVa Pharma, Inc. 宣布复合无菌注射制剂的产能大幅增加。

按产品划分的无菌复合药房市场规模和预测&ndash ; 2021 年和 2028 年

基于管理的洞察路线

基于根据给药途径,无菌复合药房市场分为静脉注射、肌内注射和皮下注射。静脉注射细分市场在 2020 年占据最大市场份额,预计在预测期内将继续占据主导地位。然而,预计肌肉注射领域在预测期内的复合年增长率最高。肌内(IM)给药途径是最常见的肠胃外注射途径。许多抗生素、术前镇静剂和麻醉剂都是通过肌肉注射途径给予的。例如,2021 年 2 月,Biogen 宣布美国食品和药物管理局 (FDA) 批准了一种新的肌肉注射 (IM) 注射剂“Plegridy(聚乙二醇干扰素 beta-1a),用于治疗多发性硬化症 (MS)”。

在无菌复合药房市场运营的公司采用产品创新战略来满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌。< /p>

根据产品,无菌复方药房市场分为注射剂和输液。

根据途径根据给药方式,无菌复合药房市场分为静脉内、肌内和皮下

无菌复合药房市场规模 - 按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • >
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚< /li>
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • li>
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • < li>阿根廷
    • 其他骗局


公司简介

  • Fagron, Inc .
  • 三角复方药剂
  • B. Braun Melsungen AG
  • PharMedium Healthcare Holdings, Inc.
  • Fresenius Kabi AG
  • Avella 专业药房
  • Pencol 复合药房
  • Pavilion Complexing Pharmacy LLC
  • Pace Pharmacy
  • SandsRx
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of the sterile compounding pharmacies market?

Global sterile compounding pharmacies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for sterile compounding pharmacies market. The US is estimated to hold the largest share in the sterile compounding pharmacies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for sterile compounding pharmacies accounting fastest growth of the region during the coming years.

Who are the key players in the sterile compounding pharmacies market?

Fagron, Inc., Triangle Compounding Pharmacy, B. Braun Melsungen AG, PharMedium Healthcare Holdings, Inc., Fresenious Kabi AG, Avella Specialty Pharmacy, Pencol Compounding Pharmacy, Pavilion Compounding Pharmacy, LLC., Pace Pharmacy, and SandsRx are among the leading companies operating in the global sterile compounding pharmacies market

Which route of administration segment held the largest revenue (US$ Mn) in the sterile compounding pharmacies market?

The intravenous segment dominated the global sterile compounding pharmacies market and accounted for the largest revenue of 2,954.51 Mn in 2021.

What is meant by the sterile compounding pharmacies market?

Sterile compounding pharmacies involve creating a medication in an environment free from viruses, bacteria, or any other potentially infectious microorganisms. Such a type of compounding is intended for medications that will be administered either through an IV or an injection.

What are the driving factors for the sterile compounding pharmacies market across the globe?

Rising uptake of personalized medicines and the benefits of on-sterile compounding are the most significant factors responsible for the overall market growth.

Which segment led the sterile compounding pharmacies market?

Based on product type, injectable drugs took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

The List of Companies - sterile compounding pharmacies market

  1. Fagron, Inc.
  2. Triangle Compounding Pharmacy
  3. B. Braun Melsungen AG
  4. PharMedium Healthcare Holdings, Inc.
  5. Fresenious Kabi AG
  6. Avella Specialty Pharmacy
  7. Pencol Compounding Pharmacy
  8. Pavilion Compounding Pharmacy, LLC.
  9. Pace Pharmacy
  10. SandsRx                                    

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports